green, page-20

Jatter,

You are on the money there. I am very confident that this one will have great success at the trial level.

The simplicity and rapidly transferable allogenic nature of the cynata patented technology could well be a hallmark stem cell play.

Many articles as per the release highlight the affects of the mab's.
Suggesting it is safe with fever the side effect ?

14m cap could be multiples of come end next year. News to the upside on this one.

Osiris takeover bodes well also